Research AI

Scans

Tools

Watchlists

Home

Charts

Watchlist

Products

Cupid Ltd

CUPID

NSE

₹336.30-4.92%19 Oct 2026 at 3:58 PM

Reports

Contraceptives and Protectives

Cupid Ltd

CUPID

NSE

₹336.30

-4.92%

19 Oct 2026 at 3:58 PM

SOICxStockScans Reports

Ask AI

Contraceptives and Protectives

Indices

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Price

Charts

Documents

Edit Ratios

Mkt Cap

Market Capitalization

₹45,214Cr

Close Price

₹336.25

Industry

Contraceptives and Protectives

Price To Earnings

329.66

Price To Sales

99.89

Revenue

₹453Cr

Rev Gr TTM

Revenue Growth TTM

121.68%

PAT Gr TTM

PAT Growth TTM

188.35%

Consolidated

Standalone

Numbers

Percentage

Quarter	Dec 2021	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue RevenueCr	37	40	63	39	42	46	56	60	84	94	120	155
Growth YoY Revenue Growth YoY%	-22.8					15.7	-10.2	52.8	103.3	101.7	112.4	158.7
Expenses ExpensesCr	33	28	32	32	31	35	43	43	56	59	82	95
Operating Profit Operating ProfitCr	4	12	31	7	10	11	13	16	28	34	38	60
OPM OPM%	11.8	30.3	49.1	17.0	24.7	24.6	23.7	27.5	33.6	36.7	31.3	38.8
Other Income Other IncomeCr	0	1	3	5	6	4	5	5	6	11	12	2
Interest Expense Interest ExpenseCr	0	0	1	0	1	0	1	1	1	1	1	1
Depreciation DepreciationCr	1	1	1	1	1	1	1	1	1	1	1	1
PBT PBTCr	4	12	32	11	14	14	16	20	32	43	47	60
Tax TaxCr	1	3	8	2	4	3	4	5	8	10	11	16
PAT PATCr	2	9	24	8	10	11	12	15	24	33	36	44
Growth YoY PAT Growth YoY%	-73.8					25.1	-51.5	81.7	140.3	196.3	215.0	194.1
NPM NPM%	6.7	22.1	37.7	21.1	24.2	23.9	20.4	25.1	28.6	35.1	30.2	28.5
EPS EPS₹	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.3	0.3

Quarter	Dec 2021	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue RevenueCr	37	40	63	39	42	46	56	60	84	94	120	155
Growth YoY Revenue Growth YoY%	-22.8					15.7	-10.2	52.8	103.3	101.7	112.4	158.7
Expenses ExpensesCr	33	28	32	32	31	35	43	43	56	59	82	95
Operating Profit Operating ProfitCr	4	12	31	7	10	11	13	16	28	34	38	60
OPM OPM%	11.8	30.3	49.1	17.0	24.7	24.6	23.7	27.5	33.6	36.7	31.3	38.8
Other Income Other IncomeCr	0	1	3	5	6	4	5	5	6	11	12	2
Interest Expense Interest ExpenseCr	0	0	1	0	1	0	1	1	1	1	1	1
Depreciation DepreciationCr	1	1	1	1	1	1	1	1	1	1	1	1
PBT PBTCr	4	12	32	11	14	14	16	20	32	43	47	60
Tax TaxCr	1	3	8	2	4	3	4	5	8	10	11	16
PAT PATCr	2	9	24	8	10	11	12	15	24	33	36	44
Growth YoY PAT Growth YoY%	-73.8					25.1	-51.5	81.7	140.3	196.3	215.0	194.1
NPM NPM%	6.7	22.1	37.7	21.1	24.2	23.9	20.4	25.1	28.6	35.1	30.2	28.5
EPS EPS₹	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.3	0.3

Consolidated

Standalone

Numbers

Percentage

Financial Year	Mar 2021	Mar 2024	Mar 2025	Mar 2026	TTM
Revenue RevenueCr	149	172	184	358	453
Growth Revenue Growth%			6.9	94.9	121.7
Expenses ExpensesCr	108	121	142	241	292
Operating Profit Operating ProfitCr	41	51	42	117	160
OPM OPM%	27.7	29.5	22.7	32.6	35.4
Other Income Other IncomeCr	0	7	20	34	31
Interest Expense Interest ExpenseCr	0	2	2	3	3
Depreciation DepreciationCr	3	3	4	5	5
PBT PBTCr	38	53	55	142	183
Tax TaxCr	9	13	14	34	45
PAT PATCr	29	40	41	108	137
Growth PAT Growth%			2.6	164.7	188.3
NPM NPM%	19.5	23.2	22.3	30.3	30.4
EPS EPS₹	0.2	0.0	0.3	0.8	1.0

Financial Year	Mar 2021	Mar 2024	Mar 2025	Mar 2026	TTM
Revenue RevenueCr	149	172	184	358	453
Growth Revenue Growth%			6.9	94.9	121.7
Expenses ExpensesCr	108	121	142	241	292
Operating Profit Operating ProfitCr	41	51	42	117	160
OPM OPM%	27.7	29.5	22.7	32.6	35.4
Other Income Other IncomeCr	0	7	20	34	31
Interest Expense Interest ExpenseCr	0	2	2	3	3
Depreciation DepreciationCr	3	3	4	5	5
PBT PBTCr	38	53	55	142	183
Tax TaxCr	9	13	14	34	45
PAT PATCr	29	40	41	108	137
Growth PAT Growth%			2.6	164.7	188.3
NPM NPM%	19.5	23.2	22.3	30.3	30.4
EPS EPS₹	0.2	0.0	0.3	0.8	1.0

Consolidated

Standalone

Numbers

Percentage

Financial Year	Mar 2021	Mar 2024	Mar 2025	Mar 2026
Equity Capital Equity CapitalCr	13	13	27	134
Reserves ReservesCr	118	192	219	316
Current Liabilities Current LiabilitiesCr	21	17	21	83
Non Current Liabilities Non Current LiabilitiesCr	1	2	8	20
Total Liabilities Total LiabilitiesCr	152	320	372	553
Current Assets Current AssetsCr	122	250	282	385
Non Current Assets Non Current AssetsCr	31	70	90	168
Total Assets Total AssetsCr	152	320	372	553

Financial Year	Mar 2021	Mar 2024	Mar 2025	Mar 2026
Equity Capital Equity CapitalCr	13	13	27	134
Reserves ReservesCr	118	192	219	316
Current Liabilities Current LiabilitiesCr	21	17	21	83
Non Current Liabilities Non Current LiabilitiesCr	1	2	8	20
Total Liabilities Total LiabilitiesCr	152	320	372	553
Current Assets Current AssetsCr	122	250	282	385
Non Current Assets Non Current AssetsCr	31	70	90	168
Total Assets Total AssetsCr	152	320	372	553

Consolidated

Standalone

Financial Year	Mar 2021	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	42	8	-11	46
Investing Cash Flow Investing Cash FlowCr	-9	-80	45	28
Financing Cash Flow Financing Cash FlowCr	-33	99	-1	35
Net Cash Flow Net Cash FlowCr	0	27	32	110
Free Cash Flow Free Cash FlowCr		-17	-31	21
CFO To PAT CFO To PAT%	144.6	19.7	-27.2	42.6
CFO To EBITDA CFO To EBITDA%	101.7	15.5	-26.7	39.5

Financial Year	Mar 2021	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	42	8	-11	46
Investing Cash Flow Investing Cash FlowCr	-9	-80	45	28
Financing Cash Flow Financing Cash FlowCr	-33	99	-1	35
Net Cash Flow Net Cash FlowCr	0	27	32	110
Free Cash Flow Free Cash FlowCr		-17	-31	21
CFO To PAT CFO To PAT%	144.6	19.7	-27.2	42.6
CFO To EBITDA CFO To EBITDA%	101.7	15.5	-26.7	39.5

Consolidated

Standalone

Financial Year	Mar 2021	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr	281	3,261	1,700	11,181	45,214
Price To Earnings Price To Earnings	9.7	818.3	41.7	103.9	329.7
Price To Sales Price To Sales	1.9	19.0	9.3	31.3	99.9
Price To Book Price To Book	2.1	159.1	6.9	24.8	100.4
EV To EBITDA EV To EBITDA	6.3	63.8	39.6	94.7	295.9
Profitability Ratios Profitability Ratios
GPM GPM%		50.2	48.6	49.0	49.0
OPM OPM%	27.7	29.5	22.7	32.6	35.4
NPM NPM%	19.5	23.2	22.3	30.3	30.4
ROCE ROCE%	29.5	25.1	21.5	28.6	28.6
ROE ROE%	22.1	19.4	16.6	24.0	24.0
ROA ROA%	19.0	12.5	11.0	19.6	19.6
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

Financial Year	Mar 2021	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr	281	3,261	1,700	11,181	45,214
Price To Earnings Price To Earnings	9.7	818.3	41.7	103.9	329.7
Price To Sales Price To Sales	1.9	19.0	9.3	31.3	99.9
Price To Book Price To Book	2.1	159.1	6.9	24.8	100.4
EV To EBITDA EV To EBITDA	6.3	63.8	39.6	94.7	295.9
Profitability Ratios Profitability Ratios
GPM GPM%		50.2	48.6	49.0	49.0
OPM OPM%	27.7	29.5	22.7	32.6	35.4
NPM NPM%	19.5	23.2	22.3	30.3	30.4
ROCE ROCE%	29.5	25.1	21.5	28.6	28.6
ROE ROE%	22.1	19.4	16.6	24.0	24.0
ROA ROA%	19.0	12.5	11.0	19.6	19.6
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

	CUPID	ANONDITA
Market CapitalizationMkt CapCr	45,214	1,914
Close PriceClose₹	336.25	1,005.10
IndustryIndustry	Contraceptives and Protectives	Contraceptives and Protectives
Price To EarningsPE	329.66	48.37
Price To SalesPS	99.89	13.93
RevenueRevenueCr	453	137
Revenue Growth TTMRev Gr TTM%	121.7%	78.5%
PAT Growth TTMPAT Gr TTM%	188.3%	107.9%

	CUPID	ANONDITA
Market CapitalizationMkt CapCr	45,214	1,914
Close PriceClose₹	336.25	1,005.10
IndustryIndustry	Contraceptives and Protectives	Contraceptives and Protectives
Price To EarningsPE	329.66	48.37
Price To SalesPS	99.89	13.93
RevenueRevenueCr	453	137
Revenue Growth TTMRev Gr TTM%	121.7%	78.5%
PAT Growth TTMPAT Gr TTM%	188.3%	107.9%